Entering text into the input field will update the search result below

BEAT HeartBeam, Inc.
Stock Price & Overview

$1.990.02 (+1.02%)3:59 PM 10/04/23
NASDAQ | $USD | Post-Market: $2.08 +0.09 (+4.52%) 5:34 PM

Charts

FFO (FWD)
PE
Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Ratings Summary

Now6M ago
SA Analysts
Not CoveredRating: Not Covered
Wall Street
Not CoveredRating: Not Covered
Quant
Not CoveredRating: Not Covered

Ratings Summary

SA Analysts
Wall Street
Quant
Now3M ago6M ago
Valuation
-Rating: Not Covered
Growth
-Rating: Not Covered
Profitability
-Rating: Not Covered
Momentum
-Rating: Not Covered
Revisions
-Rating: Not Covered

See BEAT ratings with Premium.

Company Profile

HeartBeam, Inc. logo
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Employees
10
Founded
2015
Address
  • 2118 Walsh Avenue
  • Suite 210
  • Santa Clara, CA, 95050
  • United States
Phone Number
408 899 4443
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.